Search research articles
Contact Us
Filters
Showing results (121-130 of 139) with videos related to
Page
of 14
Sort By:
Journal of Medicinal Chemistry
|
September 29, 2006
A critical assessment of docking programs and scoring functions
Gregory L Warren, C Webster Andrews, Anna-Maria Capelli, et al.
Antimicrobial Agents and Chemotherapy
|
October 18, 2002
Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureus
Frank Fan, Kang Yan, Nicola G Wallis, et al.
Journal of Medicinal Chemistry
|
October 27, 2021
Structural, Electronic, and Electrostatic Determinants for Inhibitor Binding to Subsites S1 and S2 in SARS-CoV-2 Main Protease
Daniel W Kneller, Hui Li, Stephanie Galanie, et al.
Journal of Computer-Aided Molecular Design
|
February 28, 2014
Structure-guided optimization of small molecule c-Abl activators
Xuan Hong, Ping Cao, Yoshiaki Washio, et al.
Journal of Medicinal Chemistry
|
September 11, 1998
Conformationally constrained 1,3-diamino ketones: a series of potent inhibitors of the cysteine protease cathepsin K
R W Marquis, D S Yamashita, Y Ru, et al.
Journal of Medicinal Chemistry
|
October 28, 2005
Azepanone-based inhibitors of human cathepsin L
Robert W Marquis, Ian James, Jin Zeng, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 6, 2009
Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1 (SGK1) inhibitors
Marlys Hammond, David G Washburn, H Tram Hoang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 13, 2019
Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment
Julie Lang, Anna Capasso, Kimberly R Jordan, et al.
Journal of Chemical Information and Modeling
|
February 22, 2023
AI-Accelerated Design of Targeted Covalent Inhibitors for SARS-CoV-2
Rajendra P Joshi, Katherine J Schultz, Jesse William Wilson, et al.
Journal of Medicinal Chemistry
|
April 18, 2003
Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK
Mark A Seefeld, William H Miller, Kenneth A Newlander, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 139) with videos related to
Sort By:
Page
of 14
Journal of Medicinal Chemistry
|
September 29, 2006
A critical assessment of docking programs and scoring functions
Gregory L Warren, C Webster Andrews, Anna-Maria Capelli, et al.
Antimicrobial Agents and Chemotherapy
|
October 18, 2002
Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureus
Frank Fan, Kang Yan, Nicola G Wallis, et al.
Journal of Medicinal Chemistry
|
October 27, 2021
Structural, Electronic, and Electrostatic Determinants for Inhibitor Binding to Subsites S1 and S2 in SARS-CoV-2 Main Protease
Daniel W Kneller, Hui Li, Stephanie Galanie, et al.
Journal of Computer-Aided Molecular Design
|
February 28, 2014
Structure-guided optimization of small molecule c-Abl activators
Xuan Hong, Ping Cao, Yoshiaki Washio, et al.
Journal of Medicinal Chemistry
|
September 11, 1998
Conformationally constrained 1,3-diamino ketones: a series of potent inhibitors of the cysteine protease cathepsin K
R W Marquis, D S Yamashita, Y Ru, et al.
Journal of Medicinal Chemistry
|
October 28, 2005
Azepanone-based inhibitors of human cathepsin L
Robert W Marquis, Ian James, Jin Zeng, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 6, 2009
Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1 (SGK1) inhibitors
Marlys Hammond, David G Washburn, H Tram Hoang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 13, 2019
Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment
Julie Lang, Anna Capasso, Kimberly R Jordan, et al.
Journal of Chemical Information and Modeling
|
February 22, 2023
AI-Accelerated Design of Targeted Covalent Inhibitors for SARS-CoV-2
Rajendra P Joshi, Katherine J Schultz, Jesse William Wilson, et al.
Journal of Medicinal Chemistry
|
April 18, 2003
Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK
Mark A Seefeld, William H Miller, Kenneth A Newlander, et al.
Page
of 14